Mangiferin, a novel nuclear factor kappa B-inducing kinase inhibitor, suppresses metastasis and tumor growth in a mouse metastatic melanoma model. [electronic resource]
- Toxicology and applied pharmacology 09 2016
- 105-12 p. digital
Publication Type: Journal Article
1096-0333
10.1016/j.taap.2016.07.005 doi
Animals Antineoplastic Agents--pharmacology Apoptosis Regulatory Proteins--metabolism Integrins--genetics Male Matrix Metalloproteinases--genetics Melanoma, Experimental--drug therapy Mice, Inbred C57BL Protein Kinase Inhibitors--pharmacology Protein Serine-Threonine Kinases--antagonists & inhibitors RNA, Messenger--metabolism Xanthones--pharmacology NF-kappaB-Inducing Kinase